Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

InTest Reports Q4 2025 EPS of $0.10 with Revenue of $32.8 Million Amidst Improving Momentum

MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“Semi”), Auto/EV, Defense/Aerospace, Industrial, Life Sciences, and Safety/Security, today announced financial results for the fourth quarter of 2025 ended December 31, 2025. “Orders remained strong at $37.5 million for the fourth quarter as Auto/EV customers move.

InTest Corporation to Participate in the Oppenheimer 11th Annual Emerging Growth Conference

MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), automotive/EV, defense/aerospace, industrial, life sciences, and safety/security, today announced that Nick Grant, President & CEO, and Duncan Gilmour, Chief Financial Officer, will host virtual investor meetings at the Oppenheimer 11th Annual Emergin.

InTest Corporation to Participate in 14th Annual NYC Summit

MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), automotive/EV, defense/aerospace, industrial, life sciences, and safety/security, today announced that Nick Grant, President & CEO, and Duncan Gilmour, Chief Financial Officer, will participate in the 14th Annual NYC Summit on Tuesday, December 16 at.

InTest Corporation Receives $3.7 Million Medical Device Testing Order

MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), automotive/EV, defense/aerospace, industrial, life sciences, and safety/security, announced today that it was awarded a follow-on $3.7 million order by an existing customer that manufactures medical devices. Alfamation, an InTest business, will be supplyi.